+ POLICY — Keir Starmer has said ministers should be able to “look every parent in the eye” and pledge that tech can cre…− POLICY — Artificial intelligence poses a “Hiroshima”-style risk to humanity if governments do not agree to curb how it…− CLIMATE — Artificial intelligence is often associated with ludicrous amounts of electricity, and therefore planet-heati…− EDUCATION — While many schools in England have banned smartphones, in Estonia – regarded as the new European education po…− EDUCATION — In a Cambridge classroom, Joseph, 10, trained his AI model to discern between drawings of apples and drawings…− EDUCATION — OpenAI CEO Sam Altman recently told a US podcast that if he was graduating today, “I would feel like the luck…+ EDUCATION — I disagree with the decision of lecturers to use artificial intelligence to create teaching materials (‘We co…− BUSINESS — Americans are growing worried about what artificial intelligence portends for their futures. Eight in 10 Amer…
TruaceTracing the truth around AISunday, July 12, 2026
Subscribe
Health·P Space·Evidence-backed problem·Published 2026-07-12

Accurhythm za420 (pause): FDA malfunction report involving AI

The FDA received a malfunction report involving Accurhythm za420 (pause), made by Medtronic, inc.. It was reported that true pause episodes were rejected as false by the artificial intelligence (ai) algorithm. no patient complications have been reported as a result of this event.

TRV-2026-0040Official statisticsPermanent record — cite & verify
Accurhythm za420 (pause): FDA malfunction report involving AI

"Medical Laboratory" by ben.dracup, CC BY 2.0.

Main points
  • Device: Accurhythm za420 (pause); manufacturer: Medtronic, inc..
  • FDA report type: Malfunction.
  • An adverse-event report is a safety signal, not proof that the device caused the event.
Problem

An FDA adverse-event report linked Accurhythm za420 (pause) to an AI-related malfunction; the report requires investigation and does not by itself establish causality.

The rundown

It was reported that true pause episodes were rejected as false by the artificial intelligence (ai) algorithm. no patient complications have been reported as a result of this event.

The report is part of FDA’s MAUDE surveillance data. It should be read as a signal for follow-up, not a clinical conclusion or a verified incidence rate.

Sources

The debate